AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2012
Apr 4, 2012
34931_dirs_2012-04-04_b8ee48a6-1f7e-45be-8d47-7ba55d94cd2a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-04-02
Reporting Person: Sackner-Bernstein Jonathan (VP Clinical Dev & Reg Affairs)
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3